Talis Biomedical Corp. (TLIS): Bathi resik saben saham (EPS TTM)

Talis Biomedical is seeking patent monetization pathways and strategic deals to rescue the business. On GURU.Markets, the TTM annual earnings per share visualizes the market reaction, with the metric holding at -27.91. Revenues are based on the sale of rapid diagnostic systems and consumable cartridges, however, a slow sales rollout has led to excessive costs and negative operating leverage.

Talis Biomedical (TLIS) - Bathi saben saham sajroning taun lumaku saka 04.07.2022 nganti 07.09.2024

Rincian analitis lan laporan data perusahaan Talis Biomedical Corp. (TLIS)

- rega saham lan target rega konsensus:

Rega saham Talis Biomedical Corp|TLIS - Target median analis

- data kapitalisasi bursa:

Kapitalisasi pasar Talis Biomedical Corporation|TLIS - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- rincian valuasi buku bisnis:

Nilai Akuntansi saben Saham Talis Biomedical|TLIS - Nilai Akuntansi Perusahaan|Rasio Nilai Pasar marang Nilai Buku talis.bio|TLIS - Gunggung Aset Perusahaan

- data utang lan likuiditas:

Total Utang marang Modal Talis Biomedical|TLIS - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang modal Talis Biomedical Corp|TLIS - Utang agregat perusahaan|Utang-utang marang kapitalisasi buku Talis Biomedical Corporation|TLIS - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan Talis Biomedical|Rasio cepet talis.bio

- indikator bathi lan kelipatan valuasi:

TLIS - Bathi resik|Bathi sing dikarepake Talis Biomedical|TLIS - Rasio rega marang bathi|Prakiraan rega marang bathi Talis Biomedical Corp|TLIS - Koefisien bali modal nimbang wutah|Pangali EV/EBITDA Talis Biomedical Corporation|TLIS - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Talis Biomedical|TLIS - Bathi resik saben saham sajroning taun lumaku|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan talis.bio|TLIS - Wutah bathi ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Talis Biomedical

Pambiji fundamental:talis.bio (TLIS)

Produk sing diprodhuksi Talis Biomedical Corp.

Investing in Talis Biomedical (TLIS) requires a rigorous fundamental analysis of its current financial standing. This indicator measures the business's actual annual earnings per share, excluding distortions from share buybacks. By analyzing the rolling annual earnings per share of Talis Biomedical (TLIS) on GURU.Markets, an investor can discern the actual efficiency of capital. This metric is critical for Talis Biomedical (TLIS) amid a total halt in R&D and commercial stagnation. The negative trend here confirms a lack of operating profit.

Pesaing Talis Biomedical